Today: 15 May 2026
Browse Category

Earnings Reports 4 February 2026

UBS stock slides 5% after earnings as buyback and U.S. wealth outflows bite

UBS stock slides 5% after earnings as buyback and U.S. wealth outflows bite

UBS shares fell 5.2% to 35.16 Swiss francs in Zurich after the bank reported a 56% rise in fourth-quarter profit and announced a $3 billion share buyback for 2026. CFO Todd Tuckner warned outflows from the U.S. wealth unit will likely accelerate as advisers leave. UBS’s full-year net profit reached $7.8 billion. The bank’s capital return plans remain tied to pending Swiss regulatory changes.
4 February 2026
··
S&P Global stock tumbled 11% on AI disruption fears — what to watch before earnings

S&P Global stock tumbled 11% on AI disruption fears — what to watch before earnings

S&P Global shares fell 11.3% premarket Wednesday to $468.21 after a broad selloff in data and analytics stocks, triggered by fears that new generative AI tools could erode pricing power. The company recently raised its dividend and confirmed plans to spin off its Mobility division, now branded as Mobility Global, Inc. Gartner, Intuit, and Equifax also dropped over 10%. The S&P 500 closed down 0.84% Tuesday.
4 February 2026
··
Eli Lilly stock in focus before earnings after Novo warns on obesity-drug price squeeze

Eli Lilly stock in focus before earnings after Novo warns on obesity-drug price squeeze

Eli Lilly shares fell 0.5% to $998.50 in premarket trading Wednesday after a 4% drop Tuesday, following Novo Nordisk’s warning of up to a 13% drop in 2026 sales and profits. Novo cut prices and launched an oral Wegovy, while Lilly plans to cap higher-dose obesity drug prices at $399 per month for repeat cash buyers. Investors await Lilly’s Q4 results and comments on pricing and competition.
4 February 2026
···
SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

Super Micro Computer raised its fiscal 2026 revenue forecast to at least $40 billion, up from $36 billion. Shares edged up 0.1% to $29.67 premarket after December-quarter sales hit $12.7 billion, but gross margin fell to 6.3% from 9.3%. Management cited tariffs, memory shortages, and rising costs as margin pressures. The company projects at least $12.3 billion in sales for the March quarter.
4 February 2026
···
AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD shares fell 7.6% in premarket trading Wednesday after the company forecast a sequential revenue decline and projected first-quarter sales near $9.8 billion. The outlook included $100 million in MI308 AI chip sales to China, with management citing U.S. export controls as a key uncertainty. Data-center revenue rose 39% to $5.4 billion last quarter, but investors focused on AMD’s 55% adjusted gross margin versus Nvidia’s higher target.
4 February 2026
··
Novo Nordisk stock hammered as Ozempic maker warns 2026 sales may fall up to 13%

Novo Nordisk stock hammered as Ozempic maker warns 2026 sales may fall up to 13%

Novo Nordisk warned adjusted sales and operating profit may fall 5% to 13% in 2026, citing U.S. price cuts and rising competition from Eli Lilly. Shares plunged 18% in early Copenhagen trading. CEO Mike Doustdar called the U.S. price reductions for Wegovy “painful.” Novo also flagged patent expiries and pressure from compounded GLP-1 drugs.
4 February 2026
···
GSK stock swings after earnings as new CEO Luke Miels sets softer 2026 outlook

GSK stock swings after earnings as new CEO Luke Miels sets softer 2026 outlook

GSK shares rose 1.4% Wednesday morning after new CEO Luke Miels issued a 2026 outlook projecting slower sales growth and warning of possible weakness in vaccines and general medicines. The company reported 2025 sales up 7% to £32.67 billion and forecast 2026 turnover growth of 3% to 5%. Investors remain focused on GSK’s ability to manage looming HIV patent expirations.
4 February 2026
···
LSEG share price extends AI-driven slide as investors brace for BoE, earnings

LSEG share price extends AI-driven slide as investors brace for BoE, earnings

London Stock Exchange Group shares fell 1.3% to 7,086 pence by 08:07 GMT Wednesday, after plunging 12.7% the previous day. The drop followed new AI tools from Anthropic, raising fears over LSEG’s data and analytics business. Trading volume on Tuesday hit 3.2 million shares, more than double the 50-day average. LSEG disclosed a fresh buyback as investors await the Bank of England’s Feb. 5 decision and earnings later this month.
4 February 2026
····
Keppel stock price ticks higher after S$600 million contract haul as Feb 5 results loom

Keppel stock price ticks higher after S$600 million contract haul as Feb 5 results loom

Keppel Ltd shares rose 0.46% to S$10.94 in Singapore on Wednesday after its infrastructure arm secured about S$600 million in new contracts, pushing its long-term backlog past S$7.1 billion. The company will release its second-half and full-year 2025 results before market open on Thursday, with investors watching for updates on contract wins and recurring service income.
4 February 2026
··
UOB stock price edges higher as Singapore banks trade near record levels ahead of earnings

UOB stock price edges higher as Singapore banks trade near record levels ahead of earnings

United Overseas Bank shares edged up 0.13% to S$38.48 in afternoon trading Wednesday, with about 796,000 shares changing hands. The stock traded between S$38.18 and S$38.49, near its 52-week high of S$39.50. UOB’s next results are due February 24, with investors focused on net interest margin guidance and dividend signals. Market value stands at about S$63.5 billion.
4 February 2026
··
CSL Limited share price rises 2% on ASX — what to know ahead of Feb 11 results

CSL Limited share price rises 2% on ASX — what to know ahead of Feb 11 results

CSL shares rose 2.0% to A$181.70 on Wednesday, outperforming a flat health care sector as the ASX 200 gained 0.8%. Investors await CSL’s half-year results and interim dividend announcement on Feb. 11. The Reserve Bank of Australia raised rates to 3.85% this week, with another hike expected in May. CSL last cut its FY26 forecasts in October, citing weaker U.S. flu vaccination rates.
4 February 2026
·
BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results

BHP stock jumps nearly 5% as miners snap back — what investors watch before Feb. 17 results

BHP’s U.S. shares surged 4.8% to close near $72.74 Tuesday, with 5.1 million shares traded amid a broad rally in mining stocks. Rio Tinto and Vale also advanced, as commodities swung sharply on a stronger dollar and higher futures margin requirements. Investors await BHP’s half-year results due February 17. No new ASX updates from BHP since January 29.
4 February 2026
······
Eaton stock whipsaws after earnings as 2026 outlook comes in light — what to know before Wednesday’s open

Eaton stock whipsaws after earnings as 2026 outlook comes in light — what to know before Wednesday’s open

Eaton shares closed up 0.9% at $362.53 after a volatile session, then slipped 0.3% in late trading. The company forecast 2026 adjusted profit below Wall Street’s midpoint, projecting $13.00–$13.50 per share. Quarterly revenue reached $7.06 billion, just under estimates. Eaton cited margin pressures and reaffirmed plans to spin off its vehicle and eMobility unit.
4 February 2026
··
Home Depot stock beats Wall Street selloff as investors eye the next HD earnings read

Home Depot stock beats Wall Street selloff as investors eye the next HD earnings read

Home Depot shares rose 0.8% to $381.11 Tuesday, outperforming a falling market as the S&P 500 dropped 0.84% and the Nasdaq slid 1.43%. The company recently announced 800 job cuts at its Atlanta support center and a full-time office return for corporate staff. Home Depot reports fourth-quarter earnings Feb. 24, with investors focused on demand and comparable sales trends.
4 February 2026
··
1 … 57 58 59 60 61 … 247

Stock Market Today

  • SSE Valuation Divides Analysts Amid Renewables Investment Push
    May 15, 2026, 3:55 AM EDT. Analysts are divided on SSE's (LSE:SSE) valuation as price targets shift slightly to £27.38 from £27.34. JPMorgan raised its target by £3.45, and Deutsche Bank lifted its forecast to £28.50, citing confidence in SSE's execution and growth potential driven by its £20 billion capital expenditure plan focused on renewables and networks through 2027. In contrast, Goldman Sachs downgraded the stock, warning that the current share price may already reflect much of the positive outlook, signaling risks of increased volatility. Key financial assumptions show marginal changes with revenue growth expected at 9.38%, profit margins around 20.5%, and a slightly higher price-to-earnings multiple at 13.82x. Investors monitor SSE's role in offshore wind, battery storage, and decarbonization initiatives across the UK, EU, and Japan as the narrative evolves.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 15.05.2026

15 May 2026
LIVEMarkets rolling coverageStarted: May 15, 2026, 12:00 AM EDTUpdated: May 15, 2026, 3:55 AM EDT SSE Valuation Divides Analysts Amid Renewables Investment Push May 15, 2026, 3:55 AM EDT. Analysts are divided on SSE's (LSE:SSE) valuation as price targets shift slightly to £27.38 from £27.34. **JPMorgan** raised its target by £3.45, and **Deutsche Bank** lifted its forecast to £28.50, citing confidence in SSE's execution and growth potential driven by its **£20 billion capital expenditure plan** focused on renewables and networks through 2027. In contrast, **Goldman Sachs** downgraded the stock, warning that the current share price may already reflect much of
US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Go toTop